Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges
Diabetes mellitus is a complex disorder characterized by insufficient insulin production or insulin resistance, which results in a lifelong dependence on glucose-lowering drugs for almost all patients. During the fight with diabetes, researchers are always thinking about what characteristics the ide...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-02-01
|
| Series: | Nutrients |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6643/15/5/1096 |
| _version_ | 1797614663216660480 |
|---|---|
| author | Kanghong Hu Huizhong Huang Hanluo Li Yanhong Wei Chenguang Yao |
| author_facet | Kanghong Hu Huizhong Huang Hanluo Li Yanhong Wei Chenguang Yao |
| author_sort | Kanghong Hu |
| collection | DOAJ |
| description | Diabetes mellitus is a complex disorder characterized by insufficient insulin production or insulin resistance, which results in a lifelong dependence on glucose-lowering drugs for almost all patients. During the fight with diabetes, researchers are always thinking about what characteristics the ideal hypoglycemic drugs should have. From the point of view of the drugs, they should maintain effective control of blood sugar, have a very low risk of hypoglycemia, not increase or decrease body weight, improve β-cell function, and delay disease progression. Recently, the advent of oral peptide drugs, such as semaglutide, brings exciting hope to patients with chronic diabetes. Legumes, as an excellent source of protein, peptides, and phytochemicals, have played significant roles in human health throughout human history. Some legume-derived peptides with encouraging anti-diabetic potential have been gradually reported over the last two decades. Their hypoglycemic mechanisms have also been clarified at some classic diabetes treatment targets, such as the insulin receptor signaling pathway or other related pathways involved in the progress of diabetes, and key enzymes including α-amylase, α-glucosidase, and dipeptidyl peptidase-IV (DPP-4). This review summarizes the anti-diabetic activities and mechanisms of peptides from legumes and discusses the prospects of these peptide-based drugs in type 2 diabetes (T2D) management. |
| first_indexed | 2024-03-11T07:14:33Z |
| format | Article |
| id | doaj.art-6635e9965bf94d94baf687865985919f |
| institution | Directory Open Access Journal |
| issn | 2072-6643 |
| language | English |
| last_indexed | 2024-03-11T07:14:33Z |
| publishDate | 2023-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nutrients |
| spelling | doaj.art-6635e9965bf94d94baf687865985919f2023-11-17T08:19:33ZengMDPI AGNutrients2072-66432023-02-01155109610.3390/nu15051096Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and ChallengesKanghong Hu0Huizhong Huang1Hanluo Li2Yanhong Wei3Chenguang Yao4Sino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, ChinaSino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, ChinaSino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, ChinaSino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, ChinaSino-German Biomedical Center, Hubei Provincial Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Hubei University of Technology, Wuhan 430068, ChinaDiabetes mellitus is a complex disorder characterized by insufficient insulin production or insulin resistance, which results in a lifelong dependence on glucose-lowering drugs for almost all patients. During the fight with diabetes, researchers are always thinking about what characteristics the ideal hypoglycemic drugs should have. From the point of view of the drugs, they should maintain effective control of blood sugar, have a very low risk of hypoglycemia, not increase or decrease body weight, improve β-cell function, and delay disease progression. Recently, the advent of oral peptide drugs, such as semaglutide, brings exciting hope to patients with chronic diabetes. Legumes, as an excellent source of protein, peptides, and phytochemicals, have played significant roles in human health throughout human history. Some legume-derived peptides with encouraging anti-diabetic potential have been gradually reported over the last two decades. Their hypoglycemic mechanisms have also been clarified at some classic diabetes treatment targets, such as the insulin receptor signaling pathway or other related pathways involved in the progress of diabetes, and key enzymes including α-amylase, α-glucosidase, and dipeptidyl peptidase-IV (DPP-4). This review summarizes the anti-diabetic activities and mechanisms of peptides from legumes and discusses the prospects of these peptide-based drugs in type 2 diabetes (T2D) management.https://www.mdpi.com/2072-6643/15/5/1096bioactive peptidelegumetype 2 diabetes (T2D)hypoglycemic peptide |
| spellingShingle | Kanghong Hu Huizhong Huang Hanluo Li Yanhong Wei Chenguang Yao Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges Nutrients bioactive peptide legume type 2 diabetes (T2D) hypoglycemic peptide |
| title | Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges |
| title_full | Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges |
| title_fullStr | Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges |
| title_full_unstemmed | Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges |
| title_short | Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges |
| title_sort | legume derived bioactive peptides in type 2 diabetes opportunities and challenges |
| topic | bioactive peptide legume type 2 diabetes (T2D) hypoglycemic peptide |
| url | https://www.mdpi.com/2072-6643/15/5/1096 |
| work_keys_str_mv | AT kanghonghu legumederivedbioactivepeptidesintype2diabetesopportunitiesandchallenges AT huizhonghuang legumederivedbioactivepeptidesintype2diabetesopportunitiesandchallenges AT hanluoli legumederivedbioactivepeptidesintype2diabetesopportunitiesandchallenges AT yanhongwei legumederivedbioactivepeptidesintype2diabetesopportunitiesandchallenges AT chenguangyao legumederivedbioactivepeptidesintype2diabetesopportunitiesandchallenges |